Kirkland & Ellis LLP

10/16/2025 | Press release | Distributed by Public on 10/16/2025 09:32

Kirkland Advises Sihuan Pharm and Xuanzhu Biopharm on Successful Spin-off and Separate Listing of Xuanzhu Biopharm

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Kirkland & Ellis LLP published this content on October 16, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 16, 2025 at 15:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]